Sexual Function in Women with Breast Cancer: An Evidence Map of Observational Studies

Other authors

Institut Català de la Salut

[Rodrigues-Machado N] Departament de Pediatria, Obstetrícia i Ginecologia i Departament de Medicina Preventiva, Universitat Autònoma de Barcelona, Bellaterra, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Quintana MJ, Bonfill-Cosp X] Departament de Pediatria, Obstetrícia i Ginecologia i Departament de Medicina Preventiva, Universitat Autònoma de Barcelona, Bellaterra, Spain. Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Centro Cochrane Iberoamérica, Barcelona, Spain. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. [Gómez-Gómez R] Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2023-01-11T12:55:04Z

2023-01-11T12:55:04Z

2022-10-27



Abstract

Breast cancer; Psychosexual disorders; Sexual function


Cáncer de mama; Trastornos psicosexuales; Función sexual


Càncer de mama; Trastorns psicosexuals; Funció sexual


Breast cancer (BC) is the leading cause of cancer in women, and has implications for sexual function (SF). In this study, we used an evidence map to identify, describe, and organise the current available evidence regarding SF in women with BC. We searched the MEDLINE, PsycINFO, and CINAHL databases for observational studies assessing SF in women with BC published in English, Spanish, Portuguese, and French between 2000 and 2021 (sample ≥ 50 women). Of the 64 included studies (13,257 women with BC), 58 were published since 2010. Women who were married, partnered, or in relationships represented 74.1% of the entire sample. Only a single study was conducted on women representing a sexual minority. We identified 22 assessment instruments and 40 sexual dysfunction (SdF) domains. The number of publications on SF in women with BC has increased in the last 10 years, but still remains low. Some groups of women are underrepresented, and some SdF domains are underdiagnosed, with the assessment instrument used affecting which domains are studied. Women with BC need to be better screened, as their quality of life (QoL) is affected by SdF.

Document Type

Article


Published version

Language

English

Publisher

MDPI

Related items

International Journal of Environmental Research and Public Health;19(21)

https://doi.org/10.3390/ijerph192113976

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)